摘要
目的:总结妊娠晚期羊水过少的临床治疗体会。方法选取我院2013年10月~2014年10月间收治的妊娠晚期羊水过少患者102例,对照组应用低分子右旋糖酐+丹参注射液静滴治疗,观察组应用低分子肝素加葡萄糖注射液静脉滴注治疗,对比两组羊水指数(AFI)变化与妊娠结局。结果经过治疗,观察组羊水指数升高明显,新生儿窒息率、剖宫产率相对较低,产后出血量少,两组临床疗效差异有统计学意义(P〈0.05)。结论妊娠晚期羊水过少应用低分子肝素治疗可以增加晚期羊水指数,改善母婴结局,安全性高。
Objective The clinical treatment experience of Late Trimester Oligohydramnios is to be summarized.Methods Choose 102 Late Trimester Oligohydramnios patients who are treated in hospital from October 2013 to October 2014. Patients in control group are given combined treatment of dextran and salvia intravenous injection,while patients in study group are given joint treatment of low molecular heparin treatment and GS subcutaneous injection therapy,and then observe and compare amniotic fluid index changes as wel as pregnancy outcomes of the two groups.ResultsAfter treatment, the amniotic fluid index of study group have been improved higher than control group,besides neonatal asphyxia,caesarean section rate and bleeding amount in study group are relatively lower than control group,there is a treatment differential between the two groups,and such a differential has statistic value(P〈0.05).Conclusion Low molecular heparin treatment is much effective in treatment of patients with Late Trimester Oligohydramnios,it is beneficial to improve amniotic fluid index and maternal and neonatal outcomes with high safety; therefore, such a treatment approach is quite worthwhile to be promoted and applied clinicaly.
出处
《中国卫生标准管理》
2015年第5期123-124,共2页
China Health Standard Management
关键词
妊娠晚期
羊水过少
低分子肝素
临床治疗
Late trimester pregnancy
Oligohydramnios
Low molecular heparin
Clinical treatment